APDN: Applied Dna Sciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Applied Dna Sciences Inc (APDN).
$6.69M Market Cap.
APDN Market Cap. (MRY)
APDN Shares Outstanding (MRY)
APDN Assets (MRY)
Total Assets
$12.79M
Total Liabilities
$3.82M
Total Investments
$0
APDN Income (MRY)
Revenue
$3.43M
Net Income
-$6.99M
Operating Expense
$15.04M
APDN Cash Flow (MRY)
CF Operations
-$13.71M
CF Investing
-$407.90K
CF Financing
$13.40M
APDN Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $12,789,040 (-6.32%) | $13,651,577 (-38.69%) | $22,265,114 (54.44%) | $14,416,756 (27.12%) |
Assets Current | $8,047,671 (-0.97%) | $8,126,570 (-59.25%) | $19,943,129 (76.52%) | $11,297,801 (24.46%) |
Assets Non-Current | $4,741,369 (-14.18%) | $5,525,007 (137.94%) | $2,321,985 (-25.55%) | $3,118,955 (37.80%) |
Goodwill & Intangible Assets | $2,698,975 (0.00%) | $2,698,975 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $9,142,617 (84.66%) | $4,951,159 (-61.65%) | $12,911,829 (16.18%) | $11,113,668 (94.36%) |
Property Plant & Equipment Net | $1,198,057 (-42.29%) | $2,076,032 (-6.61%) | $2,222,988 (-26.49%) | $3,023,915 (136.68%) |
Cash & Equivalents | $6,602,363 (-16.44%) | $7,901,800 (-48.40%) | $15,314,282 (130.29%) | $6,649,988 (-15.63%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $252,785 (-6.53%) | $270,435 (-52.01%) | $563,557 (100.55%) | $281,000 (-45.01%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $432,725 (31.12%) | $330,027 (-45.20%) | $602,244 (-56.04%) | $1,369,933 (175.44%) |
Trade & Non-Trade Receivables | $328,252 (28.47%) | $255,502 (-91.67%) | $3,067,544 (9.40%) | $2,804,039 (1343.01%) |
Trade & Non-Trade Payables | $1,737,366 (-23.48%) | $2,270,388 (-37.31%) | $3,621,751 (21.07%) | $2,991,343 (55.28%) |
Accumulated Retained Earnings (Deficit) | -$309,672,755 (-2.39%) | -$302,447,147 (-3.40%) | -$292,500,088 (-2.95%) | -$284,122,092 (-5.29%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $684,115 (0.00%) | $684,115 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $739,161 (-40.28%) | $1,237,760 (0%) | $0 (0%) | $0 (0%) |
Debt Current | $545,912 (9.49%) | $498,598 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $193,249 (-73.86%) | $739,162 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $3,820,955 (-56.48%) | $8,779,165 (-6.17%) | $9,356,175 (183.19%) | $3,303,810 (-41.34%) |
Liabilities Current | $2,398,124 (-15.72%) | $2,845,421 (-32.01%) | $4,185,308 (27.90%) | $3,272,343 (-23.29%) |
Liabilities Non-Current | $1,422,831 (-76.02%) | $5,933,744 (14.75%) | $5,170,867 (16332.67%) | $31,467 (-97.70%) |
APDN Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $3,431,420 (-74.33%) | $13,367,443 (-26.43%) | $18,168,677 (101.25%) | $9,027,738 (367.40%) |
Cost of Revenue | $2,414,541 (-69.18%) | $7,834,011 (-40.27%) | $13,115,037 (188.57%) | $4,544,832 (449.01%) |
Selling General & Administrative Expense | $11,447,894 (-10.22%) | $12,751,644 (-15.54%) | $15,097,360 (17.53%) | $12,845,372 (28.05%) |
Research & Development Expense | $3,593,750 (-3.78%) | $3,735,078 (-4.86%) | $3,926,043 (-5.72%) | $4,164,434 (25.37%) |
Operating Expenses | $15,041,644 (-8.77%) | $16,486,722 (-13.33%) | $19,023,403 (6.68%) | $17,831,547 (30.74%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | -$13,675 (-111.81%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$7,088,306 (29.28%) | -$10,022,916 (-21.20%) | -$8,270,059 (42.08%) | -$14,278,439 (-9.59%) |
Net Income to Non-Controlling Interests | -$95,785 (-26.27%) | -$75,857 (-3398.94%) | -$2,168 (-127.09%) | $8,003 (574.96%) |
Net Income | -$6,992,521 (29.70%) | -$9,947,059 (-20.31%) | -$8,267,891 (42.13%) | -$14,286,442 (-9.67%) |
Preferred Dividends Income Statement Impact | $233,087 (0%) | $0 (0%) | $110,105 (0%) | $0 (0%) |
Net Income Common Stock | -$7,225,608 (27.36%) | -$9,947,059 (-18.73%) | -$8,377,996 (41.36%) | -$14,286,442 (-9.64%) |
Weighted Average Shares | $5,288 (506.42%) | $872 (45.82%) | $598 (29.72%) | $461 (76.63%) |
Weighted Average Shares Diluted | $5,288 (506.42%) | $872 (45.82%) | $598 (29.72%) | $461 (76.63%) |
Earning Before Interest & Taxes (EBIT) | -$6,992,521 (29.70%) | -$9,947,059 (-20.31%) | -$8,267,891 (42.18%) | -$14,300,117 (-10.76%) |
Gross Profit | $1,016,879 (-81.62%) | $5,533,432 (9.49%) | $5,053,640 (12.73%) | $4,482,906 (306.18%) |
Operating Income | -$14,024,765 (-28.04%) | -$10,953,290 (21.59%) | -$13,969,763 (-4.65%) | -$13,348,641 (-6.49%) |
APDN Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$407,904 (62.78%) | -$1,095,808 (-123.84%) | -$489,553 (80.79%) | -$2,548,695 (-139.61%) |
Net Cash Flow from Financing | $13,398,596 (0%) | $0 (0%) | $18,126,596 (23.27%) | $14,704,855 (-24.34%) |
Net Cash Flow from Operations | -$13,711,397 (-120.52%) | -$6,217,677 (30.74%) | -$8,976,706 (32.95%) | -$13,387,955 (-20.15%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$720,705 (90.15%) | -$7,313,485 (-184.45%) | $8,660,337 (803.07%) | -$1,231,795 (-117.04%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | -$1,062,360 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$407,904 (-1119.52%) | -$33,448 (93.17%) | -$489,553 (80.79%) | -$2,548,695 (-139.61%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | -$1,665,581 (-325.39%) |
Issuance (Purchase) of Equity Shares | $13,398,596 (0%) | $0 (0%) | $18,126,596 (10.73%) | $16,370,436 (-12.44%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $572,293 (-44.65%) | $1,033,889 (-58.95%) | $2,518,665 (51.00%) | $1,668,003 (66.62%) |
Depreciation Amortization & Accretion | $696,425 (-48.88%) | $1,362,249 (5.56%) | $1,290,480 (52.82%) | $844,438 (195.54%) |
APDN Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 29.60% (-28.50%) | 41.40% (48.92%) | 27.80% (-44.06%) | 49.70% (-12.96%) |
Profit Margin | -210.60% (-183.06%) | -74.40% (-61.39%) | -46.10% (70.88%) | -158.30% (76.53%) |
EBITDA Margin | -183.50% (-185.83%) | -64.20% (-67.19%) | -38.40% (74.23%) | -149.00% (77.21%) |
Return on Average Equity (ROAE) | -112.40% (11.36%) | -126.80% (-35.33%) | -93.70% (16.26%) | -111.90% (37.73%) |
Return on Average Assets (ROAA) | -59.50% (-3.12%) | -57.70% (-2.30%) | -56.40% (38.76%) | -92.10% (16.04%) |
Return on Sales (ROS) | -203.80% (-173.92%) | -74.40% (-63.52%) | -45.50% (71.28%) | -158.40% (76.31%) |
Return on Invested Capital (ROIC) | -578.50% (-72.43%) | -335.50% (-50.58%) | -222.80% (48.56%) | -433.10% (59.18%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.36 (77.56%) | -1.59 (-30.95%) | -1.22 (53.34%) | -2.6 (-11.86%) |
Price to Sales Ratio (P/S) | 0.75 (-36.57%) | 1.18 (112.19%) | 0.56 (-86.49%) | 4.13 (-73.67%) |
Price to Book Ratio (P/B) | 0.73 (-78.07%) | 3.34 (196.18%) | 1.13 (-68.96%) | 3.63 (-47.77%) |
Debt to Equity Ratio (D/E) | 0.42 (-76.42%) | 1.77 (144.55%) | 0.72 (144.11%) | 0.3 (-69.85%) |
Earnings Per Share (EPS) | -1,365 (88.03%) | -11,407.49 (18.23%) | -13,949.99 (55.07%) | -31,049.98 (37.65%) |
Sales Per Share (SPS) | 648.9 (-95.77%) | 15,335 (-49.54%) | 30,390.18 (55.23%) | 19,577.3 (164.82%) |
Free Cash Flow Per Share (FCFPS) | -2,670.05 (62.77%) | -7,171.23 (54.71%) | -15,833.92 (54.18%) | -34,559.77 (26.03%) |
Book Value Per Share (BVPS) | 1,728.92 (-69.56%) | 5,679.92 (-73.70%) | 21,597.21 (-10.39%) | 24,100.79 (10.12%) |
Tangible Assets Book Value Per Share (TABVPS) | 1,908.09 (-84.81%) | 12,564.72 (-66.26%) | 37,242.16 (19.12%) | 31,263.77 (-21.84%) |
Enterprise Value Over EBIT (EV/EBIT) | 1 (200.00%) | -1 (0.00%) | -1 (50.00%) | -2 (0.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.58 (177.66%) | -0.74 (47.00%) | -1.4 (32.82%) | -2.09 (15.20%) |
Asset Turnover | 0.28 (-63.53%) | 0.78 (-36.50%) | 1.22 (109.97%) | 0.58 (257.06%) |
Current Ratio | 3.36 (17.51%) | 2.86 (-40.06%) | 4.76 (38.00%) | 3.45 (62.27%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$14,119,301 (-125.87%) | -$6,251,125 (33.96%) | -$9,466,259 (40.60%) | -$15,936,650 (-30.56%) |
Enterprise Value (EV) | -$3,632,540 (-156.97%) | $6,376,072 (-34.81%) | $9,780,386 (-65.17%) | $28,081,698 (-9.63%) |
Earnings Before Tax (EBT) | -$6,992,521 (29.70%) | -$9,947,059 (-20.31%) | -$8,267,891 (42.13%) | -$14,286,442 (-9.67%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$6,296,096 (26.66%) | -$8,584,810 (-23.04%) | -$6,977,411 (48.15%) | -$13,455,679 (-6.57%) |
Invested Capital | $1,828,739 (26.72%) | $1,443,141 (-47.82%) | $2,765,524 (-38.47%) | $4,494,425 (592.88%) |
Working Capital | $5,649,547 (6.98%) | $5,281,149 (-66.49%) | $15,757,821 (96.35%) | $8,025,458 (66.79%) |
Tangible Asset Value | $10,090,065 (-7.88%) | $10,952,602 (-50.81%) | $22,265,114 (54.44%) | $14,416,756 (37.95%) |
Market Capitalization | $6,691,510 (-59.51%) | $16,526,801 (13.53%) | $14,557,246 (-63.92%) | $40,350,194 (1.50%) |
Average Equity | $6,429,696 (-18.02%) | $7,842,986 (-12.24%) | $8,936,847 (-29.99%) | $12,764,310 (76.00%) |
Average Assets | $12,141,992 (-29.52%) | $17,228,425 (15.89%) | $14,866,729 (-4.19%) | $15,516,493 (30.62%) |
Invested Capital Average | $1,208,812 (-59.23%) | $2,964,857 (-20.10%) | $3,710,654 (12.38%) | $3,301,761 (171.33%) |
Shares | 13,733 (1407.46%) | 911 (6.05%) | 859 (72.14%) | 499 (45.48%) |
